Search by Drug Name or NDC

    NDC 76045-0211-20 Midazolam 2 mg/2mL Details

    Midazolam 2 mg/2mL

    Midazolam is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is MIDAZOLAM HYDROCHLORIDE.

    Product Information

    NDC 76045-0211
    Product ID 76045-211_e7017885-3716-474c-bfc4-cda89069132c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Midazolam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Midazolam Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/2mL
    Substance Name MIDAZOLAM HYDROCHLORIDE
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Benzodiazepine [EPC], Benzodiazepines [CS]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA203460
    Listing Certified Through 2024-12-31

    Package

    NDC 76045-0211-20 (76045021120)

    NDC Package Code 76045-211-20
    Billing NDC 76045021120
    Package 24 BLISTER PACK in 1 CARTON (76045-211-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-211-00) / 2 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2021-04-16
    NDC Exclude Flag N
    Pricing Information N/A